↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$9.6MSold on the market
1Companies
Aug 6, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 202620:18 | Aug 4, 2026 | ELVNEnliven Therapeutics, Inc. | Director | S · Sell10b5-1 | $60.21 | −158,795 | 0 | -100% | −$9.6M | ||
| Aug 6, 202620:18 | Aug 4, 2026 | ELVNEnliven Therapeutics, Inc. | Director | M · Exercise10b5-1 | $10.84 | +158,795 | 158,795 | New | $1.7M |